Search For "pf"
Japan to have enough vaccines to inoculate all people over 16 by late Sept
Updated : 5 years, 1 month ago IST
Tokyo [Japan], April 18 (ANI/Sputnik): Japan will have enough coronavirus vaccines to provide them to everyone older than 16 by the end of September, Administrative Affairs Minister Taro Kono said on Sunday, in the wake of successful talks between Prime Minister Yoshihide Suga and Pfizer CEO
Read More
Risk of rare blood clots higher after Covid-19 infection than after vaccin
Updated : 5 years, 1 month ago IST
London [UK], April 16 (ANI): Researchers at Oxford University have found the risk of a rare type of blood clot is low overall, but higher for people who have been infected with Covid-19 than among people who've had the three vaccines authorized in the UK - those made by AstraZeneca, Moderna
Read More
Third dose of COVID-19 vaccine 'likely' needed within 1 year, says Pfizer
Updated : 5 years, 1 month ago IST
New York [US], April 15 (ANI): Pfizer's CEO Albert Bourla on Thursday that COVID-19 vaccine recipients will "likely" need a third dose between six to 12 months after they're fully vaccinated and suggested vaccinations for coronavirus could be needed every year.
Read More
Pfizer asks for expansion of emergency use authorization to vaccinate 12 t
Updated : 5 years, 1 month ago IST
New York [US], April 10 (ANI): Pfizer and BioNTech requested the US Food and Drug Administration (FDA) on Friday for an amendment to its emergency use authorization of its Covid-19 vaccine, to expand its use for children ages 12 to 15 in the United States.
Read More
COVID-19: US begins study assessing allergic reactions to Pfizer, Moderna
Updated : 5 years, 1 month ago IST
Washington [US], April 8 (ANI): US' National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.
Read More
US launches study of allergic reactions to COVID-19 vaccines
Updated : 5 years, 1 month ago IST
Washington [US], April 8 (ANI): The US National Institutes of Health (NIH) announced Wednesday that it has kicked off a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna Covid-19 vaccines.
Read More
Mexico grants authorisation for emergency use of India's COVID-19 vaccine,
Updated : 5 years, 1 month ago IST
Mexico City [Mexico], April 7 (ANI): The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin.
Read More
FIFA suspends Pakistan Football Federation due to third-party interference
Updated : 5 years, 1 month ago IST
Zurich [Switzerland], April 7 (ANI): The Bureau of the FIFA Council on Wednesday suspended the Pakistan Football Federation (PFF) with immediate effect due to third-party interference, which constitutes a serious violation of the FIFA Statutes.
Read More
Turkey's daily COVID-19 cases hit a new record
Updated : 5 years, 1 month ago IST
Ankara [Turkey], April 2 (ANI/Xinhua): Turkey on Thursday confirmed 40,806 new COVID-19 cases, setting a new single-day record of infections since the outbreak of the pandemic.
Read More
Pfizer-BioNTech COVID-19 vaccine protection lasts at least 'six months', p
Updated : 5 years, 1 month ago IST
New York [US], April 1 (ANI): The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine has confirmed its protection lasts at least six months after the second dose.
Read More
Pfizer to start testing freeze-dried version of Covid-19 vaccine in April
Updated : 5 years, 1 month ago IST
New York [US], March 31 (ANI): US pharmaceutical giant Pfizer and its German partner BioNTech will begin testing a freeze-dried version of its Covid-19 vaccine that will need no ultra-cold storage conditions in April, The Walls Street Journal reported, citing a source.
Read More
Pfizer-BioNTech's COVID-19 vaccine 100 pc effective in 12-15 year olds: St
Updated : 5 years, 1 month ago IST
New York [US], March 31 (ANI): Pfizer-BioNTech Covid vaccine is extremely effective in adolescents between 12 to 15 years old, perhaps even more than in adults, the companies reported on Wednesday.
Read More